PATENT CLAIM ANALYSIS

Application Number: 15910745
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "451000"]

Abstract:
Provided herein are compositions containing compounds, or pharmaceutically acceptable salts, that metabolize to monomethyl fumarate with certain pharmacokinetic parameters and methods for treating, prophylaxis, or amelioration of neurodegenerative diseases including multiple sclerosis using such compositions in a subject, wherein if the compositions contain dimethyl fumarate, the total amount of dimethyl fumarate in the compositions ranges from about 43% w/w to about 95% w/w.

Claim (Index 2):
The composition of  claim 1 , wherein the total amount of dimethyl fumarate in the composition ranges from about 50% w/w to about 80% w/w.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.38462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15686352', '15125612', '15248506', '15299535', '15582913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7364350601542989
- 35 USC 102 Novelty (BERT): 0.4992181212435189
- Combined Prediction Score: 0.7127133662632209
- Mean Citation Score: 226.95391400000003
- Max Citation Score: 236.01488
- Similarity Product: 167.46198612942698

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test